Origami Therapeutics, Inc. Employee Directory
Biotechnology ResearchCalifornia, United States2-10 Employees
Origami Therapeutics, Inc. is a preclinical-stage biotechnology company based in San Diego, California, focused on developing small-molecule protein degraders for neurodegenerative diseases. Using a proprietary discovery platform, the company aims to modify disease progression by promoting the body's natural protein disposal systems to remove disease-causing proteins, including some that elude traditional approaches. This approach seeks to build a broad pipeline and pursue partnerships with major drug developers. Its lead programs target neurodegenerative diseases such as Alzheimer’s, Parkinson’s, ALS, Frontotemporal Dementia, and Huntington’s disease. In January 2026, Origami announced a global collaboration and option agreement with Ipsen to develop a small-molecule protein degrader program for a genetic neurodegenerative disorder.